Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Bullboard Posts
Post by donmayneon Mar 20, 2020 7:40am
222 Views
Post# 30829510

American Association for Home Care letter re Round 21

American Association for Home Care letter re Round 21

“We also need CMS to suspend adding non-invasive ventilators from Round 2021 of the competitive bidding program and to protect access to this critical therapy. It also needs to prioritize provisions of PPE for providers who are providing equipment and supplies to COVID-19 patients in their homes,” Tom Ryan, president and CEO of AAHomecare, told me. He added that CMS should allow coverage for short-term-use oxygen patients who will need to be treated with oxygen after being diagnosed with COVID-19.

 

Then, AAHomecare’s regulatory staff and its Regulatory Council developed a list of priority regulatory issues and questions, according to Kim Brummett, vice president of Regulatory Affairs for the association. Those items were put into a lengthy letter and sent to CMS this week. At the top of the list: a one-year delay of competitive bidding Round 2021 implementation so that HME businesses can provide ready access to patients needing home oxygen therapy devices and services, as well as home ventilators.

https://hme-business.com/articles/2020/03/19/ednote.aspx?admgarea=mag+&m=1

https://hme-business.com/articles/2020/03/19/aahomecarecovid19.aspx

Bullboard Posts